A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Whooping Cough
Related studies linked through entity extraction aliases.
Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States
- Status
- COMPLETED
- Phase
- N/A
Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Bordetella Pertussis Colonisation Challenge Study
- Status
- UNKNOWN
- Phase
- NA
Immunising Mums Against Pertussis 3
- Status
- COMPLETED
- Phase
- N/A
The Safety of Boostrix Following Routine Immunization of Pregnant Women
- Status
- COMPLETED
- Phase
- N/A
Observational Study Describing the Immune Profile Induced By Pertussis Vaccines
- Status
- COMPLETED
- Phase
- N/A
A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Viaskin Pertussis Vaccine Trial
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Influence of BCG on TDaP-IPV Vaccination
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Maternal Tdap Immunization in Guatemala
- Status
- COMPLETED
- Phase
- PHASE2
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination
- Status
- COMPLETED
- Phase
- PHASE3
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth
- Status
- COMPLETED
- Phase
- PHASE3
Vouchers to Promote Tdap Vaccination
- Status
- COMPLETED
- Phase
- EARLY_PHASE1